Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Common Stock | Options Exercise | $73K | +50K | +39.61% | $1.46 | 176K | Sep 27, 2021 | Direct | F1 |
transaction | EVRI | Common Stock | Sale | -$1.25M | -50K | -28.37% | $25.00 | 126K | Sep 27, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Stock Option | Options Exercise | $0 | -50K | -28.16% | $0.00 | 128K | Sep 27, 2021 | Common Stock | 50K | $1.46 | Direct | F3 |
Id | Content |
---|---|
F1 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on June 11, 2021 for options originally granted on May 13, 2016. |
F2 | The shares were sold in multiple transactions at a price of $25.00. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction at the price set forth in this footnote. |
F3 | Represents an option to purchase 177,550 shares of the Company's common stock, which vested in equal annual installments over a period of four years following the date of grant. |